Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1966 AL 1980

Comparison of chocolate to cacao-free white chocolate in Parkinson's disease: a single-dose, investigator-blinded, placebo-controlled, crossover trial

Wolz M, Schleiffer C, Klingelhöfer L, Schneider C, Proft F, Schwanebeck U, Reichmann H, Riederer P, Storch A.

J Neurol. 2012 Nov;259(11):2447-51. doi: 10.1007/s00415-012-6527-1. Epub 2012 May 15.

Adenosine A2A antagonists in Parkinson's disease: what's next?

Hickey P, Stacy M.

Curr Neurol Neurosci Rep. 2012 Aug;12(4):376-85. doi: 10.1007/s11910-012-0279-2.

Nanomechanical properties of single amyloid fibrils

Sweers KK, Bennink ML, Subramaniam V.

J Phys Condens Matter. 2012 Jun 20;24(24):243101. doi: 10.1088/0953-8984/24/24/243101. Epub 2012 May 15.

Altered manganese homeostasis: implications for BLI-3-dependent dopaminergic neurodegeneration and SKN-1 protection in C. elegans

Chakraborty S, Aschner M.

J Trace Elem Med Biol. 2012 Jun;26(2-3):183-7. doi: 10.1016/j.jtemb.2012.03.011. Epub 2012 May 15.

Tremor-spectrum in spinocerebellar ataxia type 3

Bonnet C, Apartis E, Anheim M, Legrand AP, Baizabal-Carvallo JF, Bonnet AM, Durr A, Vidailhet M.

J Neurol. 2012 Nov;259(11):2460-70. doi: 10.1007/s00415-012-6531-5. Epub 2012 May 17.

Selegiline: a reappraisal of its role in Parkinson disease

Fabbrini G, Abbruzzese G, Marconi S, Zappia M.

Clin Neuropharmacol. 2012 May-Jun;35(3):134-40. doi: 10.1097/WNF.0b013e318255838b.

Controlled study of 50-Hz repetitive transcranial magnetic stimulation for the treatment of Parkinson disease

Benninger DH, Iseki K, Kranick S, Luckenbaugh DA, Houdayer E, Hallett M.

Neurorehabil Neural Repair. 2012 Nov-Dec;26(9):1096-105. doi: 10.1177/1545968312445636. Epub 2012 May 15.

Parkinson's disease and immune system: is the culprit LRRKing in the periphery?

Greggio E, Civiero L, Bisaglia M, Bubacco L.

J Neuroinflammation. 2012 Jul 9;9:94. doi: 10.1186/1742-2094-9-94.

Mitochondrial respiratory chain dysfunction: implications in neurodegeneration

Morán M, Moreno-Lastres D, Marín-Buera L, Arenas J, Martín MA, Ugalde C.

Free Radic Biol Med. 2012 Aug 1;53(3):595-609. doi: 10.1016/j.freeradbiomed.2012.05.009. Epub 2012 May 14.

Efficacy of ECT in severe obsessive-compulsive disorder with Parkinson's disease

Gadit AM, Smigas T.

BMJ Case Rep. 2012 Apr 4;2012:bcr0120125675. doi: 10.1136/bcr.01.2012.5675.

SCA6 presenting with young-onset parkinsonism without ataxia

Yun JY, Kim JM, Kim HJ, Kim YE, Jeon BS.

Mov Disord. 2012 Jul;27(8):1067-8. doi: 10.1002/mds.24977. Epub 2012 May 17.

Implications of protein structure instability: from physiological to pathological secondary structure

Sukhanova A, Poly S, Shemetov A, Bronstein I, Nabiev I.

Biopolymers. 2012 Aug;97(8):577-88. doi: 10.1002/bip.22055.

Psychotic-affective symptoms and multiple system atrophy expand phenotypes of spinocerebellar ataxia type 2

Chen KH, Lin CH, Wu RM.

BMJ Case Rep. 2012 Mar 20;2012:bcr1020115061. doi: 10.1136/bcr.10.2011.5061.

Young-onset multiple system atrophy

Kim HJ, Jeon BS, Lee JY, Yun JY, Kim YE, Paek SH.

J Neurol Sci. 2012 Aug 15;319(1-2):168-70. doi: 10.1016/j.jns.2012.04.016. Epub 2012 May 17.

Buspirone: what is it all about?

Loane C, Politis M.

Brain Res. 2012 Jun 21;1461:111-8. doi: 10.1016/j.brainres.2012.04.032. Epub 2012 Apr 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias